MUKILTEO, Wash. — — CombiMatrix Corporation (Nasdaq:CBMX – News) announced today that it has fully repaid the secured convertible debenture held by YA Global Investments, L.P., which had an original principal amount of $10.0 million. As a result of retiring this debt, the potentially dilutive reserve of approximately 1.1 million shares of common stock that […]
Assay allows for detection of expanded alleles and full mutations AUSTIN, Texas–Asuragen, Inc. announced today the results of a collaborative study with scientists at the M.I.N.D. Institute at the University of California Davis evaluating a new PCR technology that reproducibly reports mutations associated with Fragile X syndrome (FXS). The study, titled “A novel FMR1 Method […]
CENTER VALLEY, Pa. — Olympus America Inc. has signed a nonexclusive worldwide licensing agreement with Omnyx, LLC, a joint venture of GE Healthcare and the University of Pittsburgh Medical Center, allowing Omnyx to access an extensive portfolio of Olympus America patents in the field of virtual microscopy and digital pathology, to help develop solutions in […]
Results from Successful Feasibility Experiment Presented at the 11th Annual Advances in Genome Biology and Technology Meeting REDWOOD CITY, Calif. — Genomic Health, Inc. (Nasdaq: GHDX) today announced that its research scientists have developed a clinically useful method for whole genome expression analysis using standard tumor specimens that are routinely collected in clinical practice. Genomic […]
Provides superior consistency in critical diagnostic sample preparation applications PORT WASHINGTON, N.Y.–Pall Corporation, (NYSE: PLL – News), a global leader in filtration, separation and purification, has introduced its next generation 96-well filter plate that delivers consistency and reproducibility in applications, such as neonatal screening and multiplexing. The Pall AcroPrep Advance filter plate employs new design […]
OMAHA, Neb. — Transgenomic, Inc. (OTC/BB: TBIO) announced today that it has licensed on an exclusive U.S. basis intellectual property from IntegraGen SA that will enable Transgenomic to develop and commercialize a genetic test designed to assess the risk of autism in children who have older siblings diagnosed with an autism spectrum disorder. Under the […]
Thermo Scientific Products Improve Automation and Efficiency for Cytogenetics Department Runcorn, Cheshire. — Thermo Fisher Scientific Inc., the world leader in serving science, today announced that the West of Scotland Regional Cytogenetics Service has chosen the Thermo Scientific Varistain Gemini ES banding machine and Thermo Scientific ClearVue automated coverslipping machine for improved automation in the […]
Proteomic Biomarkers From a Patient’s Immune System Give Doctors and Patients a Fighting Chance SUNNYVALE, CA–Arrayit Corporation (OTC.BB:ARYC – News), a leading manufacturer of products and services for disease prevention, treatment and cure, announces that the company’s new proteomic biomarkers are leading the way to true pre-symptomatic diagnosis of a variety of debilitating and fatal […]
Control Kits Will Strengthen Affymetrix’ Diagnostic Product Portfolio AUSTIN, Texas–Asuragen Inc., a leading molecular biology diagnostic company and service provider, today announced an agreement to develop and manufacture RNA Control Kits for Affymetrix (Nasdaq:AFFX). The RNA Control Kit is intended for use with in vitro transcription (IVT) reagent kits for clinical molecular diagnostic applications that […]
Investigational AmpliChip p53 Test Designed to Screen for Genetic Mutation Tied to Therapeutic Resistance in Cancer Patients PLEASANTON, Calif. — Roche Molecular Systems, Inc. (SIX: RO, ROG; OTCQX: RHHBY) announced today a research collaboration with Merck Sharp & Dohme Corp. (a subsidiary of Merck & Co., Inc.) providing Merck access to Roche’s developmental microarray-based AmpliChip […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
